NCT05378971View on ClinicalTrials.gov

Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 15, 2022

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Multiple Myeloma
Interventions
DRUG

Pomalidomide

Pomalidomide, 2mg/d, d1-21; treatment cycles every 28days

Trial Locations (1)

730000

RECRUITING

The First Hospital of Lanzhou University, Lanzhou

All Listed Sponsors
collaborator

Beijing Health Alliance Charitable Foundation

UNKNOWN

lead

LanZhou University

OTHER